HKSE:02289 (China)
Â
Shs -H- Reg S
HK$
8.60
(-2.27%)
Jun 7
Business Description
Charmacy Pharmaceutical Co Ltd
ISIN : CNE1000023D6
Share Class Description:
HKSE:02289: Shs -H- Reg SCompare
Compare
Traded in other countries / regions
02289.Hong Kong IPO Date
2015-12-14Description
Charmacy Pharmaceutical Co Ltd is a China-based pharmaceutical distributor. It distributes Western medicine, Chinese patent medicine, and healthcare products to downstream distributors and retail terminals while conducting dealings in the third-party logistics business of medicines and providing pharmaceutical products-related consulting services. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.41 | |||||
| Equity-to-Asset | 0.18 | |||||
| Debt-to-Equity | 2.61 | |||||
| Debt-to-EBITDA | 11.4 | |||||
| Interest Coverage | 2.81 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.82 | |||||
| Beneish M-Score | -2.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.6 | |||||
| 3-Year EBITDA Growth Rate | 4.4 | |||||
| 3-Year EPS without NRI Growth Rate | 8 | |||||
| 3-Year Book Growth Rate | 3.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 12.18 | |||||
| 9-Day RSI | 21.7 | |||||
| 14-Day RSI | 29.02 | |||||
| 6-1 Month Momentum % | 17.4 | |||||
| 12-1 Month Momentum % | 73.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.07 | |||||
| Quick Ratio | 0.78 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 62.04 | |||||
| Days Sales Outstanding | 73.71 | |||||
| Days Payable | 55.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.83 | |||||
| Dividend Payout Ratio | 1 | |||||
| 3-Year Dividend Growth Rate | 28.3 | |||||
| Forward Dividend Yield % | 3.83 | |||||
| 5-Year Yield-on-Cost % | 3.75 | |||||
| Shareholder Yield % | 6.48 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 6.65 | |||||
| Operating Margin % | 2.61 | |||||
| Net Margin % | 1.17 | |||||
| FCF Margin % | -3.12 | |||||
| ROE % | 8.66 | |||||
| ROA % | 1.71 | |||||
| ROIC % | 4.66 | |||||
| ROC (Joel Greenblatt) % | 7.95 | |||||
| ROCE % | 17.64 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.54 | |||||
| PE Ratio without NRI | 16.96 | |||||
| Shiller PE Ratio | 15.93 | |||||
| PEG Ratio | 2.42 | |||||
| PS Ratio | 0.21 | |||||
| PB Ratio | 1.42 | |||||
| Price-to-Tangible-Book | 1.65 | |||||
| EV-to-EBIT | 16.46 | |||||
| EV-to-EBITDA | 13.01 | |||||
| EV-to-Revenue | 0.4 | |||||
| EV-to-FCF | -13.5 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.41 | |||||
| Price-to-Graham-Number | 1.12 | |||||
| Price-to-Net-Current-Asset-Value | 5.24 | |||||
| Earnings Yield (Greenblatt) % | 6.08 | |||||
| FCF Yield % | -16.18 | |||||
| Forward Rate of Return (Yacktman) % | 3.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Charmacy Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 4,816.605 | ||
| EPS (TTM) (HK$) | 0.52 | ||
| Beta | -0.04 | ||
| Volatility % | 91.97 | ||
| 14-Day RSI | 29.02 | ||
| 14-Day ATR (HK$) | 0.487777 | ||
| 20-Day SMA (HK$) | 11.055 | ||
| 12-1 Month Momentum % | 73.75 | ||
| 52-Week Range (HK$) | 5.9 - 20 | ||
| Shares Outstanding (Mil) | 108 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Charmacy Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Charmacy Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Charmacy Pharmaceutical Co Ltd Frequently Asked Questions
What is Charmacy Pharmaceutical Co Ltd(HKSE:02289)'s stock price today?
The current price of HKSE:02289 is HK$8.60. The 52 week high of HKSE:02289 is HK$20.00 and 52 week low is HK$5.90.
When is next earnings date of Charmacy Pharmaceutical Co Ltd(HKSE:02289)?
The next earnings date of Charmacy Pharmaceutical Co Ltd(HKSE:02289) is .
Does Charmacy Pharmaceutical Co Ltd(HKSE:02289) pay dividends? If so, how much?
The Dividend Yield %  of Charmacy Pharmaceutical Co Ltd(HKSE:02289) is 3.83% (As of Today), Highest Dividend Payout Ratio of Charmacy Pharmaceutical Co Ltd(HKSE:02289) was 1. The lowest was 0.37. And the median was 0.78. The  Forward Dividend Yield % of Charmacy Pharmaceutical Co Ltd(HKSE:02289) is 3.83%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers